Health Care Technology
Company Overview of Evariant, inc.
Evariant, inc. provides a healthcare platform for healthcare organizations to identify opportunities, measure marketing campaigns against reportable return on investment (ROI), and improve patient and physician engagement. It offers patient solutions, including Patient Market Solver that provides data to understand patients, pinpoint target audiences for marketing campaigns, and develop education and wellness programs; Patient Marketing, a multi-channel CRM solution to drive targeted growth; and Patient Engagement to manage accountable follow up to create and maintain two-way conversations. The company also offers physician solutions, including Physician Market Solver, a claims-based analyti...
308 Farmington Avenue
Farmington, CT 06032
Founded in 2008
Key Executives for Evariant, inc.
Co-Founder and Executive Vice President
Compensation as of Fiscal Year 2017.
Evariant, inc. Key Developments
Evariant Names Sudhakar Gorti as Chief Technology Officer
Dec 11 17
Evariant announced the appointment of Sudhakar Gorti, better known as SG, as Chief Technology Officer (CTO) to drive the company's global engineering efforts. Gorti joins the Evariant executive team with the strategic responsibility to deliver next-generation technology solutions that help healthcare providers optimize growth through smarter patient acquisition and retention strategies. Gorti brings over 20 years of hands-on experience leading strategic, operational technology and product development initiatives. Gorti most recently served as Integra Connect’s CTO, where he was responsible for the development of specialty EHR, population health, care management, and revenue cycle management solutions. Prior to that he served as DMGT’s CTO, and before that the Vice President and CTO at Texas Health Resources.
Evariant, Inc. Appoints Tom Schultz as Chief Growth Officer
Jul 19 17
Evariant, inc. announced that it has appointed Thomas (Tom) Schultz as Chief Growth Officer. Schultz will join the company on July 31, 2017. In his role at the company, Schultz will oversee the company’s revenue growth strategy and play a critical role in developing the company’s corporate, product, and go-to-market strategies. Schultz will report to Chief Executive Officer Clay Ritchey. Schultz brings 29 years of healthcare technology experience to the company having most recently served as Senior Vice President of Sales at HealthStream, where he was responsible for leading his team to record growth in their Workforce Development and Patient Experience solutions.
Evariant Appoints Clay Ritchey as Chief Executive Officer
Mar 29 17
Evariant announced that it has appointed Clay Ritchey as Chief Executive Officer effective March 20, 2017. William Moschella, Evariant’s co-founder and former CEO, will remain on the company’s board of directors and senior leadership team. Clay Ritchey has more than 20 years of experience driving growth and innovation in healthcare technology and services organizations. Most recently, Ritchey served as GM and Chief Marketing Officer of Imprivata.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|